跳至主要内容
临床试验/DRKS00021725
DRKS00021725尚未招募不适用

Multiplate-Analysis as prognostic marker in cerebral hemorrhage - Multiplate-2020

niversitätsklinikum der RWTH Aachen0 个研究点目标入组 150 人开始时间: 2021年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Signed declaration of consent + blood samples
  • - Age over 18 years
  • - proven intracerebral hemorrhage (CT/MRT)
  • - Ingestion of at least 1 platelet function inhibitor (test group)
  • - Unequivocal understanding of the information provided about the study

排除标准

  • - No image correlate of the initial neurological symptoms
  • - Competing prognostic factors at the onset of symptoms: e.g. medication, metabolic derailments, sepsis
  • - Persons who are in a dependency / employment relationship with one of the investigators
  • - Minority
  • - Pregnancy and breastfeeding
  • - People who are accommodated in an institution by order of a court or an official
  • - Simultaneous participation in a clinical study
  • - unwilling or unable to understand the instructions of the staff or to obey them
  • - incapable of giving consent and / or are unable to understand the nature, significance and scope of the research project and to give their consent

研究者

发起方
niversitätsklinikum der RWTH Aachen

相似试验